Strongest evidence supports use to reduce seizures, side effects of chemotherapy

10/23/17–A systematic review of published studies on the use of medical cannabis in children and adolescents finds a notable lack of studies and a minimal number of the randomized, controlled trials needed to confirm the effectiveness of a treatment. In their paper published in the journal Pediatrics, Massachusetts General Hospital (MGH) investigators Shane Shucheng Wong, MD, and Timothy Wilens, MD report that their review suggests only two pediatric uses of medical cannabis. One is to relieve chemotherapy-induced nausea and vomiting, and the other is to reduce seizures. Both are supported by existing studies. Read